P53 and MYC-regulated Squalene Epoxidase As Achilles Heel in Colorectal Cancer
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
The transcription factors p53 and MYC are often considered non-druggable targets, but their dysregulation can generate new dependencies and treatment opportunities in cancer cells. The p53 and MYC-regulated squalene epoxidase (SQLE) has been identified as a potential Achilles heel in colorectal cancer. This is of great interest because the FDA-approved anti-fungal SQLE inhibitor Terbinafine could be repurposed to treat colorectal cancer patients.
References
1.
Dhanasekaran R, Deutzmann A, Mahauad-Fernandez W, Hansen A, Gouw A, Felsher D
. The MYC oncogene - the grand orchestrator of cancer growth and immune evasion. Nat Rev Clin Oncol. 2021; 19(1):23-36.
PMC: 9083341.
DOI: 10.1038/s41571-021-00549-2.
View
2.
Lipner S, Scher R
. Onychomycosis: Treatment and prevention of recurrence. J Am Acad Dermatol. 2018; 80(4):853-867.
DOI: 10.1016/j.jaad.2018.05.1260.
View
3.
Jun S, Brown A, Chua N, Yoon J, Lee J, Yang J
. Reduction of Squalene Epoxidase by Cholesterol Accumulation Accelerates Colorectal Cancer Progression and Metastasis. Gastroenterology. 2020; 160(4):1194-1207.e28.
DOI: 10.1053/j.gastro.2020.09.009.
View
4.
Hu L, Huang W, Wang X, Xu C, Qin W, Li D
. Terbinafine prevents colorectal cancer growth by inducing dNTP starvation and reducing immune suppression. Mol Ther. 2022; 30(10):3284-3299.
PMC: 9552806.
DOI: 10.1016/j.ymthe.2022.06.015.
View
5.
Sammons M, Nguyen T, McDade S, Fischer M
. Tumor suppressor p53: from engaging DNA to target gene regulation. Nucleic Acids Res. 2020; 48(16):8848-8869.
PMC: 7498329.
DOI: 10.1093/nar/gkaa666.
View